CD274 and neoplasm: Preclinical studies have demonstrated that bintrafusp alfa can activate immune responses, leading to superior inhibition of tumour growth and metastasis compared with treatments with either a single anti‐PD‐L1 antibody or a TGF‐β trap alone.215